Deutsche Bank’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,214,418
| Closed | -$10.9M | – | 5344 |
|
|
2016
Q3 | $10.9M | Buy |
1,214,418
+496,875
| +69% | +$3.53M | 0.01% | 1257 |
|
|
2016
Q2 | $3.85M | Buy |
717,543
+25,882
| +4% | +$133K | ﹤0.01% | 1941 |
|
|
2016
Q1 | $3.18M | Sell |
691,661
-348,879
| -34% | -$1.4M | ﹤0.01% | 2059 |
|
|
2015
Q4 | $5.41M | Buy |
1,040,540
+590,863
| +131% | +$3.43M | ﹤0.01% | 1737 |
|
|
2015
Q3 | $2.72M | Buy |
449,677
+20,188
| +5% | +$247K | ﹤0.01% | 2269 |
|
|
2015
Q2 | $6.78M | Sell |
429,489
-80,560
| -16% | -$979K | ﹤0.01% | 1600 |
|
|
2015
Q1 | $5.54M | Buy |
510,049
+393,292
| +337% | +$4.01M | ﹤0.01% | 1712 |
|
|
2014
Q4 | $1.23M | Sell |
116,757
-25,636
| -18% | -$250K | ﹤0.01% | 3063 |
|
|
2014
Q3 | $1.36M | Buy |
142,393
+20,675
| +17% | +$211K | ﹤0.01% | 2804 |
|
|
2014
Q2 | $1.41M | Buy |
121,718
+66,147
| +119% | +$602K | ﹤0.01% | 2695 |
|
|
2014
Q1 | $555K | Buy |
55,571
+18,410
| +50% | +$266K | ﹤0.01% | 3265 |
|
|
2013
Q4 | $482K | Sell |
37,161
-52,504
| -59% | -$723K | ﹤0.01% | 3141 |
|
|
2013
Q3 | $1.34M | Buy |
89,665
+38,855
| +76% | +$466K | ﹤0.01% | 2748 |
|
|
2013
Q2 | $474K | Buy |
+50,810
| New | +$344K | ﹤0.01% | 3205 |
|
Deutsche Bank's RPTP Position: Q4 2016 in Review
Deutsche Bank sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 1,214,418 shares — an estimated $10.9M sold.
Deutsche Bank first reported a position in RPTP in Q2 2013 and held it in 14 quarters. The position peaked at $10.9M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- Deutsche Bank reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
- Deutsche Bank sold 1,214,418 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $10.9M.
- Deutsche Bank first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 14 quarters.
- Deutsche Bank's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $10.9M in Q3 2016.
- 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.
Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.